Kimberly-Clark cuts annual forecast as China disruption hits diaper sales

• China's market regulator announced an investigation into 'formamide issues in infant diapers' on June 22 without naming specific brands, and has provided no updates since
• Kimberly-Clark now expects 2026 organic sales growth to trail category averages by about 100 basis points, down from previous forecasts of growth in line with or above the 2.5% weighted category average
• North American volumes slipped 0.3% in Q2 as inflation and higher food and gas prices forced lower-income consumers to reduce spending

Summary: Kimberly-Clark Cuts Annual Forecast on China Disruption

Key Developments:

Kimberly-Clark reduced its annual sales and profit forecasts on August 4, citing significant damage from false social media claims in China alleging its Huggies diapers contained toxic formamide. Despite independent testing by government-certified third parties confirming product safety, the misinformation severely impacted second-quarter demand.

China Market Impact:

On June 22, China's market regulator announced an investigation into "formamide issues in infant diapers" without naming specific brands, with no updates since. The company warned that disruption in this major market will continue affecting near-term sales and profitability.

Financial Results:

• Q2 net sales rose 0.6% to $4.19 billion, missing analyst expectations of $4.22 billion
• Adjusted operating profit increased 6.2% to $757 million, aided by tariff refunds, productivity savings, and favorable currency effects
• North American volumes declined 0.3% as inflation and higher food/gas prices pressured lower-income consumers

Revised Outlook:

The company now expects 2026 organic sales growth to lag category averages by 100 basis points. Categories grew approximately 2% over the past 12 months, down from previous forecasts of matching or exceeding the 2.5% weighted category average.

Strategic Moves:

Kimberly-Clark is finalizing a roughly $1 billion acquisition of Kenvue by year-end. The company recently sold a 51% stake in its international tissue business to Suzano, creating a $3.4 billion joint venture competing with Procter & Gamble and Essity.

Market Implication: The China controversy highlights reputational risks from social media misinformation in key markets, potentially affecting other consumer goods companies operating internationally.